Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kuntai Capsule for Antipsychotic-Induced Hyperprolactinemia
ChiCTR-OPh-17011440Phase 4Not yet recruiting
- Sponsor
- Shanghai Mental Health Center
- Start
- Jun 2017
- Countries
- 1
01
Overview
Phase 4 trial of Kuntai in hyperprolactinemia, sponsored by Shanghai Mental Health Center. Primary endpoints: Serum prolactin level and Clinical symptoms related to hyperprolactinemia. Planned start Jun 2017; status: not yet recruiting.
02
Drugs
Kuntai
03
Conditions
hyperprolactinemia
Beyond the preview
Go deeper on ChiCTR-OPh-17011440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPh-17011440.